Catalyst Wire Dossier Catalyst Wire Dossier

Efzofitimod

efzofitimod · aTyr Pharma, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Efzofitimod, covering 2023-07-18 to 2026-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis [Phase 3]

See pricing